Extrapyramidal adverse events and anticholinergics use after the long-term treatment of patients with schizophrenia with the new long-acting antipsychotic Risperidone ISM®: results from matching-adjusted indirect comparisons versus once-monthly formulations of Paliperidone palmitate and Aripiprazole monohydrate in 52-week studies
- Sánchez, P.
- Álamo, C.
- Almendros, M.
- Schlueter, M.
- Tasoulas, A.
- Martínez, J.
Revista:
Annals of General Psychiatry
ISSN: 1744-859X
Año de publicación: 2023
Volumen: 22
Número: 1
Tipo: Artículo
